Title for MeetingAbstracts
Alphabetical listing of titles
ENHANCED CD4 DOWN-MODULATION BY LATE-STAGE HIV-1 NEF ALLELES IS ASSOCIATED WITH INCREASED ENV INCORPORATION AND VIRAL REPLICATION.
Enhanced CMC activity with rIL-2 in patients with HIV infection.
Enhanced computer model of HIV transmission via needle sharing.
Enhanced cost effectiveness and improved clinical outcomes in Expert Physician managed HIV primary care in an Inner City Hospital HIV Clinic.
Enhanced CTL activity against the HIV-1 tab9 minigene in a combined DNA priming-Fowlpox boosting regimen by increasing the plasmid backbone CpG content.
Enhanced Cyclosporine (CSA)-Itraconazole (ICZ) Interaction with Cola in Lung Transplant Recipients (LTR).
Enhanced cytotoxic T lymphocyte activity in whole blood related to activation markers on CD8(+) cells and to disease stage of HIV infection.
Enhanced detection rate of HIV DNA and RNA by PCR in saliva from HIV seropositive IDUs.
Enhanced DNA prime-protein boost vaccines induce potent and protective immune responses against HIV-1.
Enhanced DNA Prime-protein Boost Vaccines Induce Potent and Protective Immune Responses Against HIV-1.
Enhanced effect of insulin-like factors on glucose transport activity in the unweighted rat soleus muscle.
Enhanced Efficacy of Orally Active Cidofovir Prodrugs against Experimental Cytomegalovirus Infections.
Enhanced endogenous tnf alpha production in peripheral blood mononuclear cells of HIV-1 infected patients.
Enhanced Envelope Incorporation in Pseudovirions Produced by Co-transfection with Codon-optimized Envelope Genes.
Enhanced Expression of Granulocyte Interleukin-10 Receptor 1 (IL-10R1)during Human Endotoxemia.
Enhanced Expression of the Multidrug Efflux Pumps AcrAB and AcrEF Associated with IS Element Transposition in Escherichia coli Mutants Selected with a Fluoroquinolone.
Enhanced Fas/Fas ligand dependent activation induced apoptosis in CD4 lymphocytes from HIV seropositive patients.
Enhanced fidelity of 3TC-selected M184V HIV reverse transcriptase.
Enhanced fidelity of drug-selected M184V mutated reverse transcriptase as the basis for the effectiveness of 3TC in HIV clinical trials.
Enhanced fusion function of HIV-1 envelope glycoproteins bearing a truncated cytoplasmic tail.
Enhanced HIV-1 activity after reactivation cryostorage infected cells.
Enhanced HIV-1 expression correlates with development of AIDS: a multicenter AIDS cohort study (MACS).
Enhanced HIV-1 Gag Expression and Immunogenicity by an AAV-ITR DNA Plasmid Vector Encoding the Antigen as a Lysosomal Membrane Protein Chimera.
Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine (ddI) plus hydroxyurea.
Enhanced Humoral Immune Responses Elicited by DNA Vaccination with HIV gp120-C3d Fusion Constructs.
Enhanced Immune responses induced by optimized plasmid vaccines encoding IL-15 or engineered B7 costimulatory molecules.
Enhanced immunodeficiency in hemophiliacs co-infected with HIV-1 and HTLV-I.
Enhanced Immunogencity of Dual Export Cytokine Adjuvanted DNA Vaccines for HIV-1.
Enhanced immunogenicity and virus clearance efficacy using DNA-based Semliki Forest Virus replicon followed by recombinant Fowl pox virus booster in mice.
Enhanced immunogenicity in humans of an HIV subunit vaccine regimen employing priming with a vaccinia gp160 recombinant virus (vac/env) by boosting with recombinant HIV envelope glycoprotein (rgp160).